Pyxis Oncology Inc (PYXS) — Defensive Interval Ratio

Latest as of September 2025: 1268 days

Pyxis Oncology Inc (PYXS) has a Defensive Interval Ratio of 1268 days as of September 2025. Defensive assets of $67.34 Million (cash $-, short-term investments $67.34 Million, receivables $-) cover 1268 days of daily cash needs of $53.10K/day. Check PYXS tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

1268 days
Days of operational coverage

Defensive Assets

$67.34 Million
Cash + ST Investments + Receivables

Daily Cash Need

$53.10K
Current Liabilities ÷ 365

Current Liabilities

$19.38 Million
USD

Pyxis Oncology Inc Defensive Interval Ratio (2022–2024)

This chart shows how Pyxis Oncology Inc's Defensive Interval Ratio has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the ratio stands at 1268 days, meaning defensive assets of $67.34 Million can fund 1268 days of operations without new revenue. Also explore how fast is Pyxis Oncology Inc growing its equity to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Pyxis Oncology Inc (2022–2024)

The table below presents the year-by-year Defensive Interval Ratio for Pyxis Oncology Inc from 2022 to 2024, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Pyxis Oncology Inc.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 2218 days $107.46 Million $48.44K/day $- $107.46 Million ▲ +665 days
2023 1554 days $109.66 Million $70.57K/day $- $109.63 Million ▲ +1547 days
2022 7 days $598.00K $86.67K/day $- $0.00
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)